A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 187 participants.
Also called NCT04605991
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 187 participants
- Sponsor
- Registry
-
NCT04605991
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Puerto Rico
- Registry status
- Completed
Technical summary
Registry record NCT04605991. Allocation not applicable; no masking; primary purpose treatment. Start 2020-11-04 (actual); primary completion 2022-02-04 (actual). Results posted on 2023-03-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- LY900014
- Intervention (Drug)
- Insulin Glargine
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct04605991- Content hash
4d6ce16258c64db236e30d8cdf4e275acfae0a12f8df808b997563602bbcca52